Fig. 7
From: Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis
PRM analysis. A: HMOX1 protein expression increased in PTL treatment group; B: GCLM protein expression increased in PTL treatment group; C: IL1B protein expression decreased in PTL treatment group; D: Data and results of protein quantitative analysis